Sponsor

Taiho Pharmaceutical Co., Ltd.

Clinical research sponsor

Published trials9

Recruiting shown3

Roles2

SourceClinicalTrials.gov

Clinical trials

9 shown

Futibatinib (TAS-120) in Patients With Advanced Biliary Tract CancerNCT07710885 · lead sponsor · 2026-06-24

RECRUITING

AB122 Platform StudyNCT04999761 · lead sponsor · 2021-06-01

RECRUITING

Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesNCT04683250 · lead sponsor · 2020-12-16

RECRUITING

Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.NCT03605251 · lead sponsor · 2018-08-30

COMPLETED

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)NCT00152191 · lead sponsor · 1996-10-01

COMPLETED

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)NCT00152178 · lead sponsor · 1996-07-01

COMPLETED

A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLCNCT05773092 · collaborator · 2023-08-01

ACTIVE_NOT_RECRUITING

A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based ChemotherapyNCT01904253 · collaborator · 2013-07-01

TERMINATED

Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast CancerNCT00166543 · collaborator · 2004-05-01

COMPLETED

Sponsor roles

lead sponsor6

collaborator3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.